摘要:
The invention relates generally to methods for producing a three-dimensional (3D) tissue-engineered cardiac construct and more specifically, a vascularized 3D tissue-engineered cardiac construct and uses regarding the same. The tissue-engineered cardiac constructs of the invention share the same physiological characteristics, such as contractile function, as in vivo intact cardiac tissue.